S

Sanjivani Paranteral Ltd
BSE:531569

Watchlist Manager
Sanjivani Paranteral Ltd
BSE:531569
Watchlist
Price: 235.85 INR 0.86% Market Closed
Market Cap: 2.9B INR

Sanjivani Paranteral Ltd
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Sanjivani Paranteral Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
S
Sanjivani Paranteral Ltd
BSE:531569
Cash from Operating Activities
₹124m
CAGR 3-Years
13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Cash from Operating Activities
₹58.8B
CAGR 3-Years
12%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Cash from Operating Activities
₹42.9B
CAGR 3-Years
14%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Cash from Operating Activities
₹127.2B
CAGR 3-Years
46%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Lupin Ltd
NSE:LUPIN
Cash from Operating Activities
₹47.3B
CAGR 3-Years
N/A
CAGR 5-Years
146%
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Cash from Operating Activities
₹19.4B
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
N/A
No Stocks Found

Sanjivani Paranteral Ltd
Glance View

Market Cap
2.8B INR
Industry
Pharmaceuticals

Sanjivani Paranteral Ltd. engages in the provision of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra. Its product category includes antibiotic, anti-emetic, non-steroidal anti-inflammatory drugs (NSAID) and analgesic, antimalarial, calcium and vitamin, sedative, steroid, cardiovascular, anti-fibrinolytic, anti-coagulant, vasoconstrictor, inotropic agent, anti-spasmodic, multivitamin, nutrition, iron, NSAID and analgesic, analgesic anti spasmodic, analgesic, and NSAID. Its antibiotic includes Netilmicin Sulphate, Amikacin Sulphate, and Gentamycin Sulphate. Its anti-emetic includes Ranitidine Hydrochloride, Metoclopramide, Ondansetron, and Promethazine. Its NSAID and analgesic includes Acetaminophen Injection and Diclofenac Sodium Injection. Its calcium and vitamin include Methylcobalamin 500 mcg/ml and Nicotinic Acid 10 mg/ml. Its sedative includes Midazolam Hydrochloride, Diazepam, and Dobutamine Hydrochloride. Its Iron includes iron Sucrose. Its analgesic includes Metamizole.

SANJIVIN Intrinsic Value
134.15 INR
Overvaluation 43%
Intrinsic Value
Price
S

See Also

What is Sanjivani Paranteral Ltd's Cash from Operating Activities?
Cash from Operating Activities
124m INR

Based on the financial report for Mar 31, 2025, Sanjivani Paranteral Ltd's Cash from Operating Activities amounts to 124m INR.

What is Sanjivani Paranteral Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
13%

The average annual Cash from Operating Activities growth rates for Sanjivani Paranteral Ltd have been 13% over the past three years .

Back to Top